Xtacy Therapeutics Corp.
Xtacy Therapeutics Corp.
CSE Index:
Currency:
Xtacy Therapeutics Corp is a prospect generator that provides high growth companies with financial, operational, and management assistance in the fast-growing market for wellness consumer products. The present focus of the company is in hemp and CBD-related, psilocybin and functional mushrooms, and health-care related industries.
Xtacy Therapeutics Corp. (XTCY)
SEDAR Information
Company Info
Address
Suite 1100- 1111 Melville Street
Vancouver, BC V6E 3V6
CanadaPhone
604-484-0355Fax
604-608-5442Email
[email protected]Website
https://xtacytherapeutics.com/Listing date
Thursday, July 16, 2009Transfer Agent
Computershare Investor Services Inc.Investor Relations
604-484-0355Email
[email protected]Auditor
SHIM & Associates LLPCapitalization
Issued & Outstanding:
54576471Reserved for Issuance:
3353890Company Officers
Meris Kott, Director, CEO
Mark Ireton, Director
Lindsey Perry Jr., Director and CFO
Ashleigh Vogstad, Director
News Releases
05/12/2023
XTACY Therapeutics Expands MDMA Platform
Bulletins
25/09/2023
2023-0929 - Name and Symbol Change - Global Wellness Strategies Inc. (GWS)
le 25 septembre/September 2023
Global Wellness Strategies Inc. (GWS) has announced a name and symbol change to Xtacy Therapeutics Corp. (XTCY)
Shares will begin trading under the new name and symbol and with a new CUSIP number on September 26, 2023.
Disclosure documents are available at www.thecse.com.
